{"id":"artemether-lumefantrine-fixed-combination","safety":{"commonSideEffects":[{"rate":"10%","effect":"Nausea"},{"rate":"8%","effect":"Vomiting"},{"rate":"5%","effect":"Diarrhea"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Artemether-lumefantrine is a combination therapy used to treat malaria. Artemether works quickly to kill the parasite, while lumefantrine works more slowly to prevent the parasite from developing resistance.","oneSentence":"Artemether is a fast-acting antimalarial that acts by inhibiting the parasite's mitochondrial electron transport chain, while lumefantrine is a slow-acting antimalarial that acts by inhibiting the parasite's heme detoxification pathway.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T04:54:49.920Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Malaria"}]},"trialDetails":[{"nctId":"NCT07362498","phase":"","title":"Health Systems Implementation and Molecular Surveillance of Multiple First-Line Treatments for Uncomplicated Malaria in Western Kenya","status":"COMPLETED","sponsor":"Strathmore University","startDate":"2020-06-01","conditions":"Malaria Falciparum","enrollment":316},{"nctId":"NCT05951595","phase":"PHASE3","title":"A Study to Find Out if a Combination of 3 Medicines for the Treatment of Malaria Works as Well and is as Safe and Tolerable as Combinations of 2 Medicines","status":"RECRUITING","sponsor":"University of Oxford","startDate":"2025-09-11","conditions":"Uncomplicated Plasmodium Falciparum Malaria","enrollment":1680},{"nctId":"NCT03923725","phase":"PHASE3","title":"A Trial to Compare the Efficacy, Safety and Tolerability of Combinations of 3 Anti-malarial Drugs Against Combina-tions of 2 Anti-malarial Drugs.","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2020-09-01","conditions":"Plasmodium Falciparum Malaria (Uncomplicated)","enrollment":2583},{"nctId":"NCT03939104","phase":"PHASE3","title":"A Trial to Compare the Efficacy, Safety and Tolerability of Combinations of 3 Anti-malarial Drugs Against Combinations of 2 Anti-malarial Drugs (Asia)","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2021-06-30","conditions":"Plasmodium Falciparum Malaria (Uncomplicated)","enrollment":103},{"nctId":"NCT03355664","phase":"PHASE3","title":"Study to Compare the Triple ACT AL+AQ With the ACT AL in Cambodia and Vietnam","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2018-03-19","conditions":"Malaria, Falciparum","enrollment":310},{"nctId":"NCT01054248","phase":"PHASE3","title":"Randomised Trial of 3 Artemisinin Combination Therapy for Malaria in Pregnancy","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2010-02-16","conditions":"Malaria","enrollment":511},{"nctId":"NCT00541385","phase":"PHASE3","title":"Pyronaridine Artesunate 3:1 Granule Formulation vs. Coartem© Crushed Tablets in P. Falciparum Malaria Pediatric Patients","status":"COMPLETED","sponsor":"Medicines for Malaria Venture","startDate":"2007-10","conditions":"Malaria","enrollment":535},{"nctId":"NCT02627456","phase":"PHASE1","title":"Safety, Immunogenicity, and Protective Efficacy of Radiation Attenuated Plasmodium Falciparum NF54 Sporozoites in Healthy African Adults in Mali","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2015-12-09","conditions":"Malaria","enrollment":409},{"nctId":"NCT01845701","phase":"PHASE3","title":"Artemisinin-Based Antimalarial Combinations and Clinical Response in Cameroon","status":"COMPLETED","sponsor":"University of Yaounde 1","startDate":"2010-03","conditions":"Malaria","enrollment":720},{"nctId":"NCT01967472","phase":"NA","title":"Adherence to Antimalarial Drugs in Sierra Leone","status":"COMPLETED","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2013-09-16","conditions":"Malaria","enrollment":1145},{"nctId":"NCT02528279","phase":"NA","title":"Relapses in Plasmodium Ovale and Efficacy of Artemether-lumefantrine for Mixed Species and Non-falciparum Malaria","status":"COMPLETED","sponsor":"Albert Schweitzer Hospital","startDate":"2014-10","conditions":"Malaria","enrollment":50},{"nctId":"NCT01680406","phase":"PHASE4","title":"Ethiopia Antimalarial in Vivo Efficacy Study 2012","status":"COMPLETED","sponsor":"Centers for Disease Control and Prevention","startDate":"2012-10","conditions":"Plasmodium Vivax Infection","enrollment":398},{"nctId":"NCT02974348","phase":"PHASE3","title":"Antimalaria Drugs Susceptibility Testing for an Effective Management of Infected Patients in Sub-Sahara Africa","status":"COMPLETED","sponsor":"University of Bamenda","startDate":"2013-01","conditions":"Drug Resistant Malaria Due to Plasmodium Falciparum","enrollment":300},{"nctId":"NCT00694694","phase":"PHASE3","title":"Azithromycin + Artesunate v Artemether-lumefantrine in Uncomplicated Malaria.","status":"COMPLETED","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2008-06","conditions":"Malaria","enrollment":261},{"nctId":"NCT02741024","phase":"PHASE4","title":"Efficacy of Artesunate-amodiaquine and Artemether-lumefantrine for Uncomplicated Malaria in South Kivu, DR Congo","status":"COMPLETED","sponsor":"Medecins Sans Frontieres, Netherlands","startDate":"2013-10","conditions":"Malaria","enrollment":288},{"nctId":"NCT00852423","phase":"PHASE3","title":"Safe and Efficacious Artemisinin-based Combination Treatments for African Pregnant Women With Malaria","status":"COMPLETED","sponsor":"Institute of Tropical Medicine, Belgium","startDate":"2010-06","conditions":"Malaria in Pregnancy","enrollment":3428},{"nctId":"NCT01958905","phase":"NA","title":"Efficacy and Bio-availability of Artemether-Lumefantrine in Severely Malnourished Children","status":"COMPLETED","sponsor":"Epicentre","startDate":"2013-11","conditions":"Malaria, Severe Acute Malnutrition","enrollment":399},{"nctId":"NCT00808951","phase":"PHASE4","title":"In Vivo and in Vitro Efficacy of Antimalarial Treatments in Children in Burkina Faso","status":"COMPLETED","sponsor":"Centre Muraz","startDate":"2008-12","conditions":"Malaria","enrollment":440},{"nctId":"NCT01017770","phase":"PHASE4","title":"Artemether-lumefantrine (AL) Versus Artesunate + Amodiaquine (ASAQ) for the Treatment of Uncomplicated Falciparum Malaria in Burkina Faso","status":"COMPLETED","sponsor":"Centre Muraz","startDate":"2008-09","conditions":"Uncomplicated P. Falciparum Malaria in Children","enrollment":340},{"nctId":"NCT00393679","phase":"PHASE3","title":"Evaluation of 4 Artemisinin-based Combinations for Treating Uncomplicated Malaria in African Children","status":"COMPLETED","sponsor":"Institute of Tropical Medicine, Belgium","startDate":"2007-07","conditions":"Fever, Malaria","enrollment":4112},{"nctId":"NCT01939886","phase":"PHASE3","title":"Treatment Efficacy and Malaria TRANSmission After Artemisinin Combination Therapy 2 (TRANSACT2)","status":"COMPLETED","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2013-04","conditions":"Malaria","enrollment":219},{"nctId":"NCT00527800","phase":"PHASE3","title":"Interactions Between HIV and Malaria in African Children","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2007-08","conditions":"Malaria, HIV Infections","enrollment":351},{"nctId":"NCT01599000","phase":"PHASE4","title":"Artemether-Lumefantrine Clinical Effectiveness Study","status":"COMPLETED","sponsor":"Papua New Guinea Institute of Medical Research","startDate":"2011-03","conditions":"Parasitologically Confirmed; Malarial","enrollment":159},{"nctId":"NCT01152931","phase":"PHASE3","title":"Antioxidant Micronutrients in Malaria","status":"COMPLETED","sponsor":"University of Lagos, Nigeria","startDate":"2010-08","conditions":"Malaria","enrollment":10},{"nctId":"NCT01082731","phase":"PHASE4","title":"Efficacy of Artemisinin Combination Therapies for the Treatment of Uncomplicated P. Falciparum in Pregnancy in Brazil","status":"TERMINATED","sponsor":"Centers for Disease Control and Prevention","startDate":"2010-11","conditions":"Malaria","enrollment":6},{"nctId":"NCT01107145","phase":"PHASE4","title":"Efficacy of Artemisinin Combination Therapies for the Treatment of Uncomplicated P. Vivax in Pregnancy in Brazil (PAACT-PV)","status":"TERMINATED","sponsor":"Centers for Disease Control and Prevention","startDate":"2011-02","conditions":"Plasmodium Vivax Malaria","enrollment":16},{"nctId":"NCT01567423","phase":"NA","title":"Efficacy Study of Amodiaquine-Artesunate and Artemether-Lumefantrine for the Treatment of Uncomplicated Malaria","status":"COMPLETED","sponsor":"Epicentre","startDate":"2008-04","conditions":"Malaria, Falciparum","enrollment":301},{"nctId":"NCT00619944","phase":"PHASE4","title":"Drug Interaction Study Between Lumefantrine and Lopinavir/Ritonavir","status":"COMPLETED","sponsor":"Makerere University","startDate":"2008-02","conditions":"HIV Infections","enrollment":32},{"nctId":"NCT00620438","phase":"PHASE4","title":"Drug Interaction Between Coartem® and Nevirapine, Efavirenz or Rifampicin in HIV Positive Ugandan Patients","status":"UNKNOWN","sponsor":"Makerere University","startDate":"2008-02","conditions":"HIV Infections, Tuberculosis","enrollment":90},{"nctId":"NCT01052584","phase":"NA","title":"Ethiopia Malaria Therapeutic Efficacy Study","status":"COMPLETED","sponsor":"Centers for Disease Control and Prevention","startDate":"2009-10","conditions":"Malaria","enrollment":354},{"nctId":"NCT00699920","phase":"PHASE4","title":"Cohort Study in Uganda Comparing Artesunate + Amiodaquine (Coarsucam) Versus Artemether + Lumenfantrine (Coartem) in the Treatment of Repeated Uncomplicated Plasmodium Falciparum Malaria Attacks","status":"COMPLETED","sponsor":"Sanofi","startDate":"2008-06","conditions":"Malaria","enrollment":413},{"nctId":"NCT00790881","phase":"PHASE4","title":"Artemether/Lumefantrine and Nevirapine Interaction Study in HIV-infected Adults","status":"COMPLETED","sponsor":"University of Cape Town","startDate":"2008-10","conditions":"Malaria, HIV","enrollment":36},{"nctId":"NCT00540410","phase":"PHASE4","title":"Cohort Study in Senegal Comparing Artesunate + Amiodaquine in the Treatment of Repeated Uncomplicated Plasmodium Falciparum Malaria Attacks","status":"COMPLETED","sponsor":"Sanofi","startDate":"2007-09","conditions":"Malaria","enrollment":366},{"nctId":"NCT00902811","phase":"PHASE4","title":"Effectiveness of Artemisinin Combination Regimens in Falciparum Malaria","status":"UNKNOWN","sponsor":"Medecins Sans Frontieres, Netherlands","startDate":"2008-12","conditions":"Uncomplicated Falciparum Malaria","enrollment":600},{"nctId":"NCT00316329","phase":"PHASE3","title":"ATAQ EASY: Artesunate + Amodiaquine Fixed Dose Combination in the Treatment of Uncomplicated Plasmodium Falciparum Malaria","status":"COMPLETED","sponsor":"Sanofi","startDate":"2006-03","conditions":"Malaria","enrollment":1032}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":14,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Coartem Novartis"],"phase":"phase_1","status":"active","brandName":"Artemether-lumefantrine fixed combination","genericName":"Artemether-lumefantrine fixed combination","companyName":"Epicentre","companyId":"epicentre","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Artemether is a fast-acting antimalarial that acts by inhibiting the parasite's mitochondrial electron transport chain, while lumefantrine is a slow-acting antimalarial that acts by inhibiting the parasite's heme detoxification pathway. Used for Malaria.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}